AAP doubles down on harmful Hepatitis B vaccine mandate for all newborns – NaturalNews.com

For over three decades, the American Academy of Pediatrics (AAP) has enforced a medical tyranny upon the most vulnerable among us: newborn babies. With robotic adherence to a corrupt vaccine schedule, pediatricians have been weaponized to inject every infant, on their first day of life, with a hepatitis B vaccine that babies DO NOT NEED in almost every instance.

This one-size-fits-all policy is not medicine or about improving immunity to disease; it is a predatory chemical assault on a developing immune system, designed not to protect children but to funnel billions into pharmaceutical coffers, while locking parents into a childhood vaccine schedule and subsequent, rigorous pediatrician appointments that push dozens more doses into their baby’s bloodstream.

With the reformed CDC advisory panel taking a more cautious approach with the Hepatitis B vaccine (removing their recommendation for newborns) it becomes increasingly clear that the medical establishment had it completely wrong about hepatitis B vaccines for over thirty years.

And now, as the truth emerges, the AAP is digging in its heels, choosing conflict and coercion over science and child safety. Why would an organization entrusted with pediatric health continue to push a vaccine for a sexually transmitted and blood-borne disease onto all newborns whose mothers have tested negative or on mothers who know that they don’t have the disease in the first place?

Key points:

• The AAP continues to recommend a universal hepatitis B vaccine at birth despite a recent CDC advisory panel vote to limit the shot only to infants born to infected mothers.
• Medical freedom advocates argue the AAP’s stance is motivated by financial conflicts of interest with vaccine manufacturers, not child safety.
• The hepatitis B vaccine contains 250 micrograms of aluminum, a neurotoxin that, when injected into a newborn, exceeds FDA safety guidelines by more than tenfold.
• Clinical trials for the vaccine followed infants for only four to five days, utterly failing to study long-term autoimmune or neurological damage.
• Adverse events for this vaccine can be mild to debilitating, ranging from arthritis to anaphylaxis.
• Infant immune systems are underdeveloped, unable to handle the toxins in the Hep B vaccines, and may not respond to the science anyway.
• Parents are being coerced and frightened into compliance by a medical system that prioritizes profitable protocol over individualized care.

Hep B vaccine trials only followed infants for five days

The foundation of this scandal is a vaccine that was never adequately tested for safety. As detailed by researchers, the original clinical trials for Merck’s and GlaxoSmithKline’s hepatitis B vaccines followed infants for a mere four to five days post-injection. This is a pharmaceutical trick: make the study so short you will never see the chronic problems. Aluminum, a key adjuvant in the shot, is a known toxin whose serious side effects, including autoimmune disorders, can take months or years to manifest.

By only looking for immediate reactions like swelling or fever, these trials provided a free pass for a product that injects a massive dose of a neurotoxin directly into an infant’s bloodstream. Dr. Paul Thomas highlighted the insanity of this dosage, noting that the 250 micrograms of aluminum in a single hepatitis B shot is over ten times the FDA’s maximum daily exposure limit for a newborn. This is not prevention; this is poisoning.

Parents are terrorized by pediatricians and hospital staff to comply

This coercive system of automatic, one size fits all Hep B vaccines at birth is propped up by fear and terrorizing parents at their most vulnerable state after having a baby. Parents are told their child might die from liver cancer if they refuse the shot, a terrifying but statistically absurd threat for a baby born to a healthy, monogamous, hepatitis B-negative mother. In some cases, hospital staff bully parents, making them feel illegitimate for not complying. Many parents “choose” to get the vaccine because they fear that the hospital won’t let them leave. The bullying in the medical field is the reason why so many parents are breaking away from vaccines altogether and choosing vax freedom and natural immunity for their family.

This isn’t to say that these diseases aren’t real. When it comes to dealing with Hepatitis B, the global incidence of hepatitis B in women is approximately three percent, meaning about ninety-seven percent of newborns have virtually no risk of contracting the disease in infancy. Yet, hospitals and pediatricians act as enforcers on every parent, even though they may test negative.

One parent shared how a hospital pediatrician refused to shake their hand and attempted to brand them as negligent for declining the vaccine for their healthy newborn. This is not an isolated report. Parents report being forced to sign alarming waivers and are bombarded with apocalyptic warnings during the vulnerable moments after birth, a tactic designed to break down informed consent and secure compliance for a needless intervention.

AAP fighting to keep Hep B vaccines going in all newborn arms

Why does the AAP fight so viciously to maintain this status quo? Follow the money. The organization receives substantial funding from the very pharmaceutical giants, Merck and GSK, that manufacture the only hepatitis B vaccines available for newborns in the U.S. Karl Jablonowski, Ph.D., of Children’s Health Defense, stated plainly, “Both companies are also corporate donors to the AAP. Do the interests of selling drugs and those of keeping our children healthy conflict?”

The recent vote by the reformed CDC Advisory Committee on Immunization Practices to end the universal birth dose is a seismic shift that exposes the old regime’s failures. Yet, the AAP immediately rejected this science-based update. Dr. Aaron M. Milstone, speaking for the AAP, claimed, “Children will acquire hepatitis B and die as a result of these recommendations,” a statement that pediatrician Dr. Michelle Perro called irresponsible fearmongering.

In a medical landscape that is lacking informed consent and is at war with itself, parents must understand that they are the final authority. They are not merely patients in a system; they are the guardians of their child’s biological integrity. Protecting a newborn from this needless chemical assault should be the top priority when facing a predatory system that values schedule adherence over individualized health.

The science is evolving, and it is moving away from the AAP’s dangerous dogma. The old guard of “robotic pediatricians” who foolishly followed the industry-controlled CDC for decades must now reckon with new guidelines that admit the birth dose is not essential for most babies. This is just the beginning. The entire childhood vaccine schedule is under scrutiny now, and parents have the power and the right to say no and choose a better way. Do not let a pediatrician, a hospital, or a compromised academy sign your baby’s body up for a lifetime of potential neurological damage for a disease they will never catch. The only consent that matters is yours.

Scientific review finds Hepatitis B vaccine linked to anaphylaxis, Guillain-Barre Syndrome, demyelinating diseases, arthritis, and SIDS

An important 1994 scientific review details the development, use, and safety profile of Hepatitis B vaccines. Originally derived from human plasma in the early 1980s, the vaccine was later produced via recombinant DNA technology in yeast to address safety concerns. It was recommended for universal infant administration in the U.S. in 1991.

The vaccine is administered in a multi-dose series, with over 90% of healthy children and adults developing protective antibodies. Common side effects are generally mild and transient, including local soreness and low-grade fever.

The review rigorously assesses potential causal links to serious adverse events. It concludes the evidence establishes a causal relation between the Hepatitis B vaccine and anaphylaxis, a severe allergic reaction, though this is deemed an “exceedingly rare” event. Consequently, it acknowledges the vaccine could theoretically cause fatal anaphylaxis.

For other conditions, the evidence shows a causal relationship with Hep B vaccines and other serious health issues:

• Guillain-Barré Syndrome (GBS)
• Other demyelinating diseases like optic neuritis, transverse myelitis, and multiple sclerosis
• Acute or chronic arthropathy (arthritis)
• Sudden Infant Death Syndrome (SIDS)

The report notes that while VAERS contains reports of SIDS following vaccination, no published epidemiological studies at the time confirmed a causal link (Isn’t it time to start taking this causal link seriously and study it effectively?) The review emphasizes the challenge of distinguishing true vaccine effects from coincidental events, especially given that the peak age for SIDS coincides with routine infant vaccinations.

Underdeveloped immune system may render the vaccine ineffective for babies anyway

A more recent review in the Journal of Viral Hepatitis has ignited a critical debate on the foundational principles of the hepatitis B vaccine, particularly its universal administration to newborns. The study argues that while the vaccine may reduce overt disease, it fails to prevent covert infections from mutated viruses and questions the real-world meaning of antibody elevation as a sole measure of efficacy. This critique is bolstered by findings from a comprehensive meta-analysis (Tahir et al., Vaccines 2024), which details a multitude of factors impairing the vaccine’s immune response, including advanced age, obesity, smoking, genetic predispositions, and comorbidities like diabetes, HIV, and chronic organ diseases.

This list of confounders raises a profound concern when applied to newborns. An infant’s immune system is inherently underdeveloped and immature, operating fundamentally differently from that of a healthy adult. Given the myriad of established factors that can hinder vaccine response in developed individuals, it is plausible that newborns may receive little to no immunological benefit from the shot due to the confounding factor of their own nascent immune function. Coupled with the extremely low risk of contracting hepatitis B for infants born to negative mothers, and the common adverse reactions noted, the logic of a universal mandate is deeply flawed. The evidence suggests a more prudent path: reserving the hepatitis B vaccine for high-risk adults, rather than subjecting all children to a potentially ineffective and unnecessary medical intervention.

Sources include:

ChildrensHealthDefense.org

Pubmed.gov

Pubmed.gov